BiVictriX Therapeutics Plc (BVX.L)
GBp 10.0
(17.65%)
GBp 10.0
(17.65%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.02 Million GBP | -1.68% |
| 2022 | -2.97 Million GBP | -57.32% |
| 2021 | -1.89 Million GBP | -285.92% |
| 2020 | -490 Thousand GBP | 6.84% |
| 2019 | -526 Thousand GBP | -9.58% |
| 2018 | -480 Thousand GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.67 Million GBP | -2.45% |
| 2023 Q2 | -1.39 Million GBP | 2.46% |
| 2023 FY | -3.02 Million GBP | -1.68% |
| 2023 Q4 | -1.63 Million GBP | -17.63% |
| 2022 FY | -2.97 Million GBP | -57.32% |
| 2022 Q2 | -1.55 Million GBP | -43.12% |
| 2022 Q4 | -1.42 Million GBP | 8.06% |
| 2021 FY | -1.89 Million GBP | -285.92% |
| 2021 Q4 | -1.08 Million GBP | -158.47% |
| 2021 Q2 | -419 Thousand GBP | -29.72% |
| 2020 FY | -490 Thousand GBP | 6.84% |
| 2020 Q2 | -167 Thousand GBP | 0.0% |
| 2020 Q4 | -323 Thousand GBP | -93.41% |
| 2019 FY | -526 Thousand GBP | -9.58% |
| 2018 FY | -480 Thousand GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|